US regulators on Monday authorised Pfizer and BioNTech’s Covid-19 vaccine for use in children as young as 12, widening the country’s inoculation programme as vaccination rates have slowed significantly. The US Food and Drug Administration (FDA) said it was amending the EUA to include millions of children aged 12 to 15. It is the first Covid-19 vaccine to be authorised in the US for this age group, seen as an important step for getting children back into schools safely. Pfizer and BioNTech asked the FDA to expand their EUA to include the younger age group in early April. Many states only opened to non-high risk individuals in that age group in early April.

Source: The Irish Times May 10, 2021 21:56 UTC